Summary
Latest filing:
Kenneth Krogulski is Director of CUMBERLAND PHARMACEUTICALS INC (CPIX). 14 SEC Form 4 filings on record going back to 2024, most recently on 20 March 2026. Lifetime open-market purchases: $56K. Historical track record: 4/5 stars across 184 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction Kenneth Krogulski has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 184 |
| Purchases with forward-return data | 184 |
| 30-day win rate | 52% |
| 90-day win rate | 43% |
| Avg 5-day return | +1.46% |
| Avg 30-day return | +7.37% |
| Avg 90-day return | +47.96% |
| Best 30-day return | +121.70% |
Trading Pattern
InsiderAlpha's records for Kenneth Krogulski go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. The typical open-market purchase is $302 (184 buys totaling $56K). The largest single buy on record is $707 of CPIX in 2024. 141 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Kenneth Krogulski. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James Jones - $10K of CPIX open-market activity on record
- A. J. Kazimi - $10K of CPIX open-market activity on record
- Caroline Young - $5K of CPIX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kenneth Krogulski?
Kenneth Krogulski is a corporate insider, tracked as Director of CUMBERLAND PHARMACEUTICALS INC (CPIX). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kenneth Krogulski last file a Form 4?
The most recent primary Form 4 on record is dated 20 March 2026, one of 14 filings going back to 2024.
Has Kenneth Krogulski been buying or selling stock?
Recorded transactions: 184 open-market purchases ($56K) and 0 open-market sales across all tracked filings.
How accurate is Kenneth Krogulski's historical track record?
Across 184 tracked purchases, Kenneth Krogulski averaged +7.4% avg 30-day return with a 52% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Kenneth Krogulski's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kenneth Krogulski and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial